8-K: Perrigo Restructures Reporting Segments

Perrigo Company plc has transitioned to a product-category-based reporting structure to better align financial disclosures with its strategic priorities.

Summary

• Perrigo has reorganized its reporting segments into three primary categories: Self Care, Specialty Care, and Infant Formula.
• The 'All Other' category now encompasses Oral Care and Dermacosmetics.
• The company has shifted its primary segment profitability measure from segment operating income to segment adjusted operating income.
• Historical financial data for 2024 and 2025 has been recast to reflect these new segments for improved comparability.
• The changes do not impact historical consolidated financial position, results of operations, or cash flows.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral-to-negative update; while the structural transparency is a positive governance step, the underlying financial data reveals a massive $1.3 billion goodwill impairment and declining year-over-year sales.

Positives

• Improved alignment of financial reporting with the company's operational structure and strategic vision.
• Enhanced transparency for investors by providing recast historical data across the new segment categories.
• The transition to adjusted operating income provides a clearer view of ongoing operational performance by excluding non-recurring items.

Negatives

• The company recorded a significant goodwill impairment charge of $1.3 billion in the fourth quarter of 2025.
• Total consolidated net sales for 2025 were $4.25 billion, down from $4.37 billion in 2024.
• Infant Formula segment profitability has been volatile, showing a loss in two of the four quarters of 2025.

Risks

• Potential for further impairment charges if the carrying value of reporting units continues to exceed estimated fair value.
• Ongoing volatility in the Infant Formula segment, which remains sensitive to operational and market conditions.
• Reliance on non-GAAP measures to explain performance, which may obscure underlying GAAP-based financial challenges.
• Exposure to litigation and restructuring costs that continue to impact reported operating income.

Future Outlook

Management intends to use the new reporting segments and adjusted operating income metrics for future planning, forecasting, and performance evaluation to better reflect the company's strategic priorities.

Management Comments

• The changes were implemented to reflect how the chief operating decision maker makes operating decisions and allocates resources.
• The company believes non-GAAP measures are useful to investors in evaluating ongoing operating trends and facilitating comparability.

Industry Context

StockSavvy.ai notes that Perrigo's shift toward product-category-based reporting is a common trend among diversified consumer health companies seeking to simplify complex geographic structures and highlight core growth drivers in the competitive OTC and specialty health markets.

Comparison to Industry Standards

• The use of adjusted operating income as a primary segment metric aligns with industry peers like Haleon and Kenvue, who also emphasize non-GAAP metrics to strip out acquisition-related amortization.
• The significant goodwill impairment is consistent with broader industry challenges in the consumer health sector regarding valuation adjustments for legacy assets.

Corporate Governance

Legal Proceedings

• The company continues to incur costs related to unusual litigation, which are excluded from adjusted operating income.

Stakeholder Impact

• Shareholders may be concerned by the large goodwill impairment charge impacting GAAP earnings.
• Investors gain better visibility into the performance of specific product categories like Self Care and Infant Formula.

Next Steps

• Continue utilizing the new reporting segments for future financial disclosures.
• Ongoing monitoring of the Infant Formula segment performance.

Key Dates

Recommendation

While the structural change is a positive step for transparency, the significant goodwill impairment and declining sales suggest underlying operational headwinds that warrant a cautious 'hold' until the new segment performance stabilizes.

Keywords

Perrigo, Financial Reporting, Segment Restructuring, Consumer Health, Self Care, Infant Formula, Goodwill Impairment